🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy, safety and pharmacok...
Status
Terminated
Location
Chongqing Public Health Medical Center
Start Date
2022-01-28
Trial ID
NCT05242042
To evaluate the safety and pharmacokinetic characteristics after the admini...
Status
Completed
Location
Bundang CHA university global clinical trials center Institutional Review Board
Start Date
2022-05-03
Trial ID
NCT06165965
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, multiple-dose study to inve...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05-02
Trial ID
NCT05355077
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics and safety of...
Status
Completed
Location
Shanghai Xuhui Central Hospital
Start Date
2023-05-08
Trial ID
NCT05895812
Treatments Being Tested
This study is a single center, single dose, non-randomized, open design cli...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2023-03-18
Trial ID
NCT05802810
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of JT001 (...
Status
Completed
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2022-04-04
Trial ID
NCT05341609
Real-world disease outcomes and safety in patients with mild to moderate CO...
Status
Active Not Recruiting
Location
Peking university first hospital
Start Date
2023-08-31
Trial ID
NCT06142201
Treatments Being Tested
Evaluate the pharmacokinetic differences of the main metabolite 116-N1 of J...
Status
Completed
Location
The First Hospital of Jilin University Ethics Committee
Start Date
2023-07-28
Trial ID
NCT06093230
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of JT001 (...
Status
Terminated
Location
Shanghai Public Health Clinical Center
Start Date
2022-03-14
Trial ID
NCT05279235
Treatments Being Tested
Evaluate the safety and tolerability of oral JT001 tablets in elderly subje...
Status
Completed
Location
Shanghai Xuhui Central Hospital
Start Date
2023-07-12
Trial ID
NCT06093308
Treatments Being Tested